AnPac Bio Stock Gains On Robust Growth In Commercial Testing Volume In Q2


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


  • AnPac Bio-Medical Science Co Ltd (NASDAQ:ANPC) has announced strong growth in test volume in 1H of 2021. The total number of paid customers and testing volume increased almost 110% compared with 1H of 2020. 
  • For 2Q, total paid tests and paid cancer tests increased approximately 280% Q/Q and around 270%, respectively.
  • The Company expects that the strong test volume growth will continue throughout this year.
  • Price Action: ANPC shares are up 9.5% at $4.39 during the premarket session on the last check Tuesday.

20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: EarningsNewsPenny StocksHealth CareGeneralBriefs